We analysed four STAT3 chromatin immunoprecipitation sequencing (ChIP-seq) datasets across three different cancer types and identified two prominent STAT3 binding peaks within the ERCC4 promoter region (Fig. S4D). This evidence concerns the gene ERCC4 and cancer.